Torx® Software, a collaboration between Cresset® Software and Discovery and Elixir™ Software, is a small molecule drug discovery platform. It connects medicinal chemistry teams, CROs and external partners securely across the entire DMTA (design-make-test-analyze) platform. Design, review, prioritization, resource allocation and scheduling are all separate parts of a complex process that can lead to productivity bottlenecks and slow the whole team down. Torx removes these bottlenecks by reimagining the end-to-end process to find a more team-friendly, cloud-based and productivity-centric approach. *Accelerate drug discovery projects *Fast deployment time *Customizable interface *Simple integration with third party informatics *Monitor efficiency *Maximize resources *Reduce costs *Efficient, real-time exchange with multiple CROs and partners Torx Make (formerly chemTraX) is powered by Elixir Software's iTraX technology.
| Website | https://www.cresset-group.com/torx/ |
| Revenue | $18.2 million |
| Employees | 8 (2 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+15 more
(view full list)
|
| Industry | Software Development |
| Keywords | Drug Discovery Platform, Pharma Software, Small Molecule Drug Discovery, Life Science Software, Biotechnology Software, Chemical Informatics, Cheminformatics Software, Molecular Modeling Software, Drug Development Software, Structure-Based Drug Design, Data Management Platform, Scientific Collaboration |
| Competitors | Springer Nature Group, The National Institutes of Health, Wiley, Elsevier, IEEE, American Chemical Society, MDPI, Sage, BMC, Entrepreneurship & Regional Development - An International Journal +41 more (view full list) |
Looking for a particular Torx® Software employee's phone or email?
The Torx® Software annual revenue was $18.2 million in 2026.
2 people are employed at Torx® Software.